Sila Realty Trust, Inc. (NYSE:SILA) Given Consensus Recommendation of “Hold” by Brokerages

Sila Realty Trust, Inc. (NYSE:SILA) has received an average recommendation of “Hold” from the seven research firms that are currently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 12 month target price among brokers that have issued ratings on the stock in the last year is $29.50.

Several research firms recently commented on SILA. Freedom Capital cut shares of Sila Realty Trust from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 21st. Wall Street Zen cut Sila Realty Trust from a “hold” rating to a “sell” rating in a report on Saturday, April 25th. Wells Fargo & Company boosted their price target on Sila Realty Trust from $25.00 to $30.00 and gave the company an “equal weight” rating in a report on Tuesday, April 21st. BNP Paribas Exane reaffirmed a “neutral” rating and set a $31.00 price objective (up from $28.00) on shares of Sila Realty Trust in a research report on Tuesday, April 21st. Finally, Weiss Ratings upgraded Sila Realty Trust from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, May 11th.

Institutional Trading of Sila Realty Trust

Hedge funds and other institutional investors have recently made changes to their positions in the business. Private Wealth Group LLC bought a new stake in shares of Sila Realty Trust in the second quarter worth $209,000. Empowered Funds LLC bought a new position in Sila Realty Trust in the first quarter valued at $244,000. Western Wealth Management LLC bought a new position in Sila Realty Trust in the first quarter valued at $94,000. Bank of America Corp DE increased its stake in Sila Realty Trust by 20.5% in the 1st quarter. Bank of America Corp DE now owns 99,519 shares of the company’s stock valued at $2,357,000 after buying an additional 16,935 shares during the last quarter. Finally, Arkadios Wealth Advisors bought a new stake in Sila Realty Trust during the 1st quarter worth about $311,000.

Sila Realty Trust Stock Performance

Shares of SILA stock opened at $30.36 on Friday. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.27 and a current ratio of 1.27. Sila Realty Trust has a 52 week low of $21.94 and a 52 week high of $30.63. The company’s 50 day moving average price is $30.32 and its two-hundred day moving average price is $27.55. The company has a market capitalization of $1.68 billion, a P/E ratio of 45.31 and a beta of 0.94.

Sila Realty Trust (NYSE:SILA) last released its quarterly earnings results on Thursday, May 7th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. Sila Realty Trust had a net margin of 18.64% and a return on equity of 2.81%. The company had revenue of $52.66 million during the quarter, compared to analysts’ expectations of $49.77 million. On average, analysts expect that Sila Realty Trust will post 2.3 earnings per share for the current fiscal year.

Sila Realty Trust Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Shareholders of record on Wednesday, May 20th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Wednesday, May 20th. This represents a $1.60 dividend on an annualized basis and a yield of 5.3%. Sila Realty Trust’s dividend payout ratio is 238.81%.

Sila Realty Trust Company Profile

Sila Realty Trust, Inc, headquartered in Tampa, Florida, is a net lease real estate investment trust with a strategic focus on investing in the large, growing, and resilient healthcare sector. The Company invests in high quality healthcare facilities along the continuum of care, which, we believe, generate predictable, durable, and growing income streams. Our portfolio comprises high quality tenants in geographically diverse facilities, which are positioned to capitalize on the dynamic delivery of healthcare to patients.